2,521
edits
Difference between revisions of "Field-Flow fractionation (FFF)"
Jump to navigation
Jump to search
Field-Flow fractionation (FFF) (view source)
Revision as of 14:07, 12 October 2022
, 14:07, 12 October 2022→Wyatt Technology
Lars Krause (talk | contribs) |
Lars Krause (talk | contribs) |
||
| Line 114: | Line 114: | ||
===Wyatt Technology=== | ===Wyatt Technology=== | ||
{{Infobox provider-field-flow fractionation|Company=Wyatt Technology|Country=USA|Contact=support@wyatt.com|Webpage=https://www.wyatt.com|Technology name=Eclipse|TRL=9|Temperature=20-50}} | {{Infobox provider-field-flow fractionation|Company=Wyatt Technology|Country=USA|Contact=support@wyatt.com|Webpage=https://www.wyatt.com|Technology name=Eclipse|TRL=9|Temperature=20-50|Image=Wyatt.png}} | ||
More than 40 years ago, Wyatt Technology's scientists invented commercial light scattering instruments incorporating lasers as their light source. The company is developing laser light scattering hardware, software, training and services to meet customer needs for over three decades. Along they added several related technologies to their product line including dynamic light scattering, refractometry, viscometry, and field-flow fractionation. . Wyatt’s tools are used in discovery, product development, QC and manufacturing settings for determining the properties of novel therapeutics such as nano-drug carriers, vaccines, biopolymers and proteins; as well as synthetic polymers and nanoparticles. | More than 40 years ago, Wyatt Technology's scientists invented commercial light scattering instruments incorporating lasers as their light source. The company is developing laser light scattering hardware, software, training and services to meet customer needs for over three decades. Along they added several related technologies to their product line including dynamic light scattering, refractometry, viscometry, and field-flow fractionation. . Wyatt’s tools are used in discovery, product development, QC and manufacturing settings for determining the properties of novel therapeutics such as nano-drug carriers, vaccines, biopolymers and proteins; as well as synthetic polymers and nanoparticles. | ||